Maito, Sahiros B.
HRN: 24-38-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2024
CEFTAZIDIME 1GM (VIAL)
01/15/2024
01/23/2024
IV
1gram
Q8hrs
CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes